Overview

Dose-Finding, Safety, Pharmacodynamic Effect Study of Sodium Nitrite Inhalation Solution in Normal, Healthy Volunteers

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
This study is designed to investigate the safety and tolerability of AIR001 Inhalation Solution when administered under conditions of hypoxia and to identify dose levels of drug resulting in a reduction in pulmonary arterial pressure under these hypoxic conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Aires Pharmaceuticals, Inc.
Treatments:
Pharmaceutical Solutions